Celebrating 1 Year of SCRI Oncology Partners
SCRI Oncology Partners shared a post on LinkedIn:
“Celebrating 1 Year of SCRI Oncology Partners.
One year ago, SCRI Oncology Partners took a bold step forward, establishing ourselves as an independent, patient-focused oncology group.
Our mission was simple yet ambitious: to provide compassionate, cutting-edge cancer care that spans from standard treatments to innovative clinical trials, including first-in-human studies.
Over the past year, we’ve had the privilege of serving our community, walking alongside our patients through their journeys, and contributing to the future of oncology through groundbreaking research with Sarah Cannon Research Institute.
Our dedicated team has worked tirelessly to combine personalised care with the latest advancements, ensuring every patient has access to the best possible outcomes.
As we celebrate this milestone, we want to thank:
- Our incredible patients and their families, who inspire us every day.
- Our team of providers and staff, whose passion and expertise make our vision a reality.
- Our research collaborators and partners, who help us push the boundaries of cancer care.
- The multiple physicians who have chosen to join us over the past year to continue to grow our footprint and impact for patients. Krish Patel, Deepak Bhamidipati, Mark E. Cooper.
Here’s to many more years of progress, innovation, and hope! If you’re looking for expert care or want to learn more about our clinical trial opportunities, we’re here for you.
Together, we’re stronger. Here’s to the next chapter of SCRI Oncology Partners!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023